Tremella fuciformis Polysaccharide Induces Apoptosis of B16 Melanoma Cells via Promoting the M1 Polarization of Macrophages
Molecules · 2023
DOI: 10.3390/molecules28104018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lingna Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Melanoma, Experimental. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Guangdong Provincial Key Laboratory of Plant Resources Biorefinery, the Project of Rejuvenation of Science and Technology for Mongolia.
Abstract (Originalsprache)
Anti-tumor activity of Tremella fuciformis polysaccharides (TFPS) has been widely reported, but its mechanism remains poorly understood. In this study, we established an in vitro co-culture system (B16 melanoma cells and RAW 264.7 macrophage-like cells) to explore the potential anti-tumor mechanism of TFPS. Based on our results, TFPS exhibited no inhibition on the cell viability of B16 cells. However, significant apoptosis was observed when B16 cells were co-cultured with TFPS-treated RAW 264.7 cells. We further found that mRNA levels of M1 macrophage markers including iNOS and CD80 were significantly upregulated in TFPS-treated RAW 264.7 cells, while M2 macrophage markers such as Arg-1 and CD 206 remained unchanged. Besides, the migration, phagocytosis, production of inflammatory mediators (NO, IL-6 and TNF-α), and protein expression of iNOS and COX-2 were markedly enhanced in TFPS-treated RAW 264.7 cells. Network pharmacology analysis indicated that MAPK and NF-κB signaling pathways may be involved in M1 polarization of macrophages, and this hypothesis was verified by Western blot. In conclusion, our research demonstrated that TFPS induced apoptosis of melanoma cells by promoting M1 polarization of macrophages, and suggested TFPS may be applied as an immunomodulatory for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
- Infinitus Company Ltd., 11 Sicheng Road, Tianhe District, Guangzhou 510000, China.
- State Key Laboratory of Food Nutrition and Safety, Tianjin University of Science and Technology, Tianjin 300457, China.
- College of Food Science and Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.
- Guangdong Provincial Key Laboratory of Plant Resources Biorefinery, Guangdong University of Technology, Guangzhou 510006, China.
ORCID-Profile: Zhenyuan Zhu
Förderung
- National Natural Science Foundation of China
- the Guangdong Provincial Key Laboratory of Plant Resources Biorefinery
- the Project of Rejuvenation of Science and Technology for Mongolia
- Research and Development Projects in Key Areas of Guangdong Province
- Project of Rejuvenation of Science and Technology for Mongolia
Zitieren
APA
Xie, L., Liu, G., Huang, Z., Zhu, Z., Yang, K., Liang, Y., Xu, Y., Zhang, L., & Du, Z. (2023). Tremella fuciformis Polysaccharide Induces Apoptosis of B16 Melanoma Cells via Promoting the M1 Polarization of Macrophages. Molecules. https://doi.org/10.3390/molecules28104018
Vancouver
Xie L, Liu G, Huang Z, Zhu Z, Yang K, Liang Y, et al. Tremella fuciformis Polysaccharide Induces Apoptosis of B16 Melanoma Cells via Promoting the M1 Polarization of Macrophages. Molecules. 2023. doi:10.3390/molecules28104018
BibTeX
@article{Xie2023,
author = {Xie, Lingna and Liu, Guangrong and Huang, Zebin and Zhu, Zhenyuan and Yang, Kaiye and Liang, Yiheng and Xu, Yani and Zhang, Lanyue and Du, Zhiyun},
title = {Tremella fuciformis Polysaccharide Induces Apoptosis of B16 Melanoma Cells via Promoting the M1 Polarization of Macrophages},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28104018}
}
EUVIMED